Healthscope – FY18 Results

FY18 results for HSO were below expectations, with underlying EBITDA falling 4.4% to A$376 million

Healthscope will establish an unlisted REIT holding hospital real estate on a lease back arrangement, HSO will retain 51% interest. The deal should help to unlock over $1 billion.

You’re not a member!  Trial today

Funds will be used for capital management initiatives, repaying debt and funding future growth.

Healthscope goes ex-div 3.5c on the 6th September.

Healthscope

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.